Member Info for The.Italian

thanks crisplyex. for those who don't want to sign up to the independent try https://www.ladbible.com/news/labgrown-lion-meat-could-be-set-for-tables-at-uk-restaurants-20220330

sorry,meant to add that we may therefore hear news of the results during sept 2022 if they release them prior to regulatory submission.nothing is cast in stone of course.

the RNS of 20th dec 2021 sets out the last known position very clearly.planned regulatory submission end of Q3 2020 and targeted OTC approval Q1 2023.

also worth noting thatLO didn't unload any when we spiked on eu news.presumably they must feel that there is more to come.

thanks jet7 for your reply.i understand and respect your view,particularly regarding our erstwhile bete noire,who i think did have an extremely negative effect on sentiment.i do take a slightly different view of lombard's involvement,which has been supportive since their involvement in dec2019.of course they are not doing it out of the goodness of their hearts,but presumably see more value coming in due course,which will hopefully benefit us all. fingers crossed!

afternoon jet7.just wondering what your concern is over LO's holding. are you worried that it may presage a sale or takeover before FDA approval and before the company's potential has been maximised? just interested in your view.

https://www.thenationalnews.com/weekend/2022/04/01/how-superhero-compound-graphene-is-forging-a-uk-uae-bond/ courtesy of hoverflyman on ADVFN.not sure if it has any direct relevance to VRS but it is encouraging in a general sense.

fairly chunky trade 0f £542.5k @77.5p just before 4pm.presumably had to be a buy given subsequent s/p movement.

interesting article marxistpizza. it serves in part to address lurka's question below.we all know the difficulties of producing at scale and economic viability from the numerous articles available.this article is another example of how,hopefully,over time technological advances will start to address these issues.

https://www.punchline-gloucester.com/articles/aanews/fast-fashion-crackdown-good-news-for-alternatives courtesy of jointer on ADVFN.nothing to get excited about ,but just posting for information,

tbh the more i think about the less i see anyone paying anything upfront,before fda approval.just can't see it happening im afraid.its not as though we get the impression pharmas are falling over themselves to get a piece of the action no apparent EU/asia sales is hardly going to help.hope im wrong.

morning bignose.yes i noticed the withholding tax reference with a wry smile.also found the milestone description a bit puzzling,but given ERP's well known lack of precision in the use of language,im not reading too much into it.make or break year? absolutely!

yes heimdal.i wondered why nothing mentioned in the general narrative.deliberate low profile perhaps? time will tell.

continued. if there have been positive discussions with a potential us partner it might explain the radio silence over the trial etc.hope this isn't just wishful thinking.

for me the reference to the milestone revenue from a potential us partner is the most important point.i don't think this has been mentioned before.let us hope it is a suggestion of real substance based on actual discussions,rather than just some pie in the sky aspiration designed to keep the auditors of their backs and to enable a going concern statement to be given.

salient points for me as follows.1/no or virtually no revenue from fortacin/senstend.
2/no information re type c meeting and RLD protocol(see below)
3/intention to repay approx 2/5ths of galloway loan on basis the balance is left rot time being.4/bank loan figure is less than at dec 2020,but not particularly significant and may just reflect a particular point in time,or remaining funds from share sales.
5/ in cash flow reference(page22) to a milestone income of approx $17m from a potential commercial partner in the us by end of 2022.see next post

https://www.investorschronicle.co.uk/ideas/2022/03/28/priced-for-a-profitable-recovery/ courtesy of arregius on ADVFN

very interesting lakeside,thanks.more confirmation of what appears to be the relentless, and dare i say, unstoppable direction of travel

although very much a sideshow in the overall context, i have had an email today telling me the new app is due for its "soft"launch in april. not clear whether it is an entirely separate app from the existing or whether it is just an additional functionality,but whatever it is it seems to be aimed at mental health well being.

another quite volatile day, with s/p trading between 0.108 and 0.135 hkd.